Literature DB >> 29866886

NSG-S mice for acute myeloid leukemia, yes. For myelodysplastic syndrome, no.

Emmanuel Griessinger1,2, Michael Andreeff3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29866886      PMCID： PMC6058791          DOI： 10.3324/haematol.2018.193847

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Myelodysplastic syndrome can propagate from the multipotent progenitor compartment.

Authors:  Kevin Rouault-Pierre; Alexander E Smith; Syed A Mian; Irene Pizzitola; Austin G Kulasekararaj; Ghulam J Mufti; Dominique Bonnet
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

2.  Versatile humanized niche model enables study of normal and malignant human hematopoiesis.

Authors:  Ander Abarrategi; Katie Foster; Ashley Hamilton; Syed A Mian; Diana Passaro; John Gribben; Ghulam Mufti; Dominique Bonnet
Journal:  J Clin Invest       Date:  2017-01-09       Impact factor: 14.808

3.  Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.

Authors:  M Feuring-Buske; B Gerhard; J Cashman; R K Humphries; C J Eaves; D E Hogge
Journal:  Leukemia       Date:  2003-04       Impact factor: 11.528

Review 4.  Humanized hemato-lymphoid system mice.

Authors:  Alexandre P A Theocharides; Anthony Rongvaux; Kristin Fritsch; Richard A Flavell; Markus G Manz
Journal:  Haematologica       Date:  2016-01       Impact factor: 9.941

5.  Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia Patients.

Authors:  Emmanuel Griessinger; Fernando Anjos-Afonso; Jacques Vargaftig; David C Taussig; François Lassailly; Thomas Prebet; Véronique Imbert; Marielle Nebout; Norbert Vey; Christian Chabannon; Andrew Filby; Frederic Bollet-Quivogne; John G Gribben; Jean-François Peyron; Dominique Bonnet
Journal:  Cancer Res       Date:  2016-03-09       Impact factor: 12.701

6.  Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment.

Authors:  Ye Chen; Rodrigo Jacamo; Yue-xi Shi; Rui-yu Wang; Venkata Lokesh Battula; Sergej Konoplev; Dirk Strunk; Nicole A Hofmann; Andreas Reinisch; Marina Konopleva; Michael Andreeff
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

7.  AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model.

Authors:  Mark Wunderlich; Benjamin Mizukawa; Fu-Sheng Chou; Christina Sexton; Mahesh Shrestha; Yogen Saunthararajah; James C Mulloy
Journal:  Blood       Date:  2013-01-24       Impact factor: 22.113

8.  Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival.

Authors:  Giuseppe Monaco; Marina Konopleva; Mark Munsell; Clinton Leysath; Rui-Yu Wang; C Ellen Jackson; Martin Korbling; Elihu Estey; John Belmont; Michael Andreeff
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

9.  AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.

Authors:  Daniel J Pearce; David Taussig; Kazem Zibara; Lan-Lan Smith; Christopher M Ridler; Claude Preudhomme; Bryan D Young; Ama Z Rohatiner; T Andrew Lister; Dominique Bonnet
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

10.  Preclinical modeling of myelodysplastic syndromes.

Authors:  K Rouault-Pierre; S A Mian; M Goulard; A Abarrategi; A Di Tulio; A E Smith; A Mohamedali; S Best; A-M Nloga; A G Kulasekararaj; L Ades; C Chomienne; P Fenaux; C Dosquet; G J Mufti; D Bonnet
Journal:  Leukemia       Date:  2017-06-02       Impact factor: 11.528
View more
  1 in total

1.  The killing effect of novel bi-specific Trop2/PD-L1 CAR-T cell targeted gastric cancer.

Authors:  Wei Zhao; Lizhou Jia; Mingjiong Zhang; Xiaochen Huang; Peng Qian; Qi Tang; Jin Zhu; Zhenqing Feng
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.